Robert Redfield - Apr 1, 2024 Form 4 Insider Report for Onconova Therapeutics, Inc. (TRAW)

Role
Acting Chief Medical Officer
Signature
/s/ Robert Redfield
Stock symbol
TRAW
Transactions as of
Apr 1, 2024
Transactions value $
$0
Form type
4
Date filed
4/3/2024, 08:07 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TRAW Common Stock Award +97.5K 97.5K Apr 1, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents an award of restricted stock units that will vest in four equal annual installments beginning April 1, 2025. Each restricted stock unit will convert into common stock of Traws Pharma, Inc. (f/k/a Onconova Therapeutics, Inc.), par value $0.01 per share, on a one-for-one basis.